Update on OCTGT Guidance Development Program

First Page		Document Content
Date: 2008-03-27 11:33:16 Food and Drug Administration Clinical research Pharmaceutical industry Validation Cord blood Gene therapy Center for Biologics Evaluation and Research Current Good Tissue Practices Biology Biotechnology Stem cells		Update on OCTGT Guidance Development Program Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 40,37 KB Share Document on Facebook

	Tracking towards GMP conditions: Replacing FBS with Human Umbilical Cord Blood Serum for the culture of human MSC Vivek Tanavde, Bioinformatics Institute. Background: A major stumbling block in the utilization of MSC in DocID: 1vjJi - View Document
	UMBILICAL CORD BLOOD BANKING A guide for parents This guide has been elaborated by the Council of Europe European DocID: 1rf0W - View Document
	why wouldn’t you become a member of CORD? THE STRENGTH OF CORD… DocID: 1r8XY - View Document
	Stem Cell Treatments for Cerebral Palsy Factsheet for patients and families Crystal Ruff,* Jared Wilcox,* Michael Fehlings STEM CELLS AND CEREBRAL PALSY Cerebral palsy (CP) is an umbrella term which DocID: 1qNPL - View Document
	Position Paper on Umbilical Cord Blood Donations – The Junior Leagues of New Jersey State Public Affairs Committee (SPAC) is a nonpartisan committee made up of representatives of the eight Junior Leagues in DocID: 1qCcp - View Document